(Press-News.org) In the largest genetic analysis of depression to date, Veterans Affairs researchers identified many new gene variants that increase the risk for depression. The groundbreaking study helps researchers better understand the biological basis of depression and could lead to better drug treatments.
The study involved genetic data on more than 300,000 participants of VA's Million Veteran Program (MVP), along with more than a million subjects from other biobanks, including 23andMe. With such a large participant pool, the researchers were able to spot trends in genetic risk of depression not previously known.
Co-primary investigator Dr. Joel Gelernter, a researcher with the VA Connecticut Healthcare System and Yale University School of Medicine, explained the significance of the findings. "This study uncovered more of the genetic architecture of depression than was previously known," he said. "This implicates new regions of the genome for more targeted investigation and allows us to use this information to identify drugs that are currently approved for other indications and might be repurposed for treatment of depression."
The findings appear in the May 27, 2021, issue of the journal Nature Neuroscience.
Major depressive disorder is the most common psychiatric disorder. About 20% of the U.S. population experiences depression. Over 300 million people worldwide, 4% of the global population, have depression. For U.S. Veterans, that rate is 11%.
Previous research has shown that genetics play a large role in depression risk. To gain more insight into exactly what genes are involved, VA researchers and colleagues assembled a large dataset to perform a genome-wide association study (GWAS). A GWAS compares the genomic codes of many people to see what gene variants people with a particular condition tend to have in common. This project was the first genomic study of depression to include more than a million participants.
The researchers first analyzed the genomes of over 250,000 MVP participants of European ancestry. They then combined the findings with previous analyses from several other genetic repositories--the UK Biobank, FinnGen, and 23andMe. The other biobanks added more subjects, for a total of more than 1.2 million participants, to the primary study.
The analysis revealed 178 loci--specific parts of the genome--that are involved in a person's risk for depression. The finding includes 77 loci not detected in previous research.
The analysis also identified 223 single -nucleotide polymorphisms (SNPs) at these 178 locations that appear to affect a person's depression risk. An SNP is a specific variation of a single DNA building block.
The researchers also examined the genomes of nearly 60,000 Veterans of African ancestry in the MVP database. They found that 125 of the SNPs identified in the European ancestry group (61%) directly affected the African ancestry participants' risk for depression.
The team validated the results by checking them against 1.3 million additional samples from 23andMe, a private genetic testing company. This check confirmed the findings of the initial analysis. By combining such large databases, the researchers were able to draw broader and more accurate conclusions. "One of the underappreciated elements of GWAS is how reproducible the findings are," explained co-lead author Dr. Daniel Levey of the VA Connecticut Healthcare System and Yale University School of Medicine. "Now that we've achieved adequate power, we are finding great consistency in findings from different groups study. We hope this consistency provides a stable foundation for new discoveries that can improve treatments."
Further analysis revealed genetic overlap between depression and several other psychiatric conditions, which has been suggested by other studies. Depression shares genetic risk factors with anxiety disorders and PTSD, as well as with risky behavior and cannabis use disorder, the study found.
The findings could be used to identify new drug therapies for treating depression, according to the researchers. By identifying what genes are involved in depression, researchers may be able to repurpose existing drugs that are known to act on these genes. For example, riluzole, a drug used to treat amyotrophic lateral sclerosis (ALS), could be of interest for depression. It works on one of the genes identified by the MVP study.
Gelernter explained how MVP makes groundbreaking studies such as this possible. "This study, like many before it, highlights the value of the MVP sample in identifying genes for common genetic traits, especially those that are important in the veteran population. Another unique value of the MVP is that it allows us to study populations other than Europeans. We didn't find nearly as much in African-ancestry subjects as in European-ancestry, but we made a good start, and our results will be of great value in future meta-analysis efforts," he said. "This is a critical advantage of the MVP."
Together, the results greatly add to the understanding of how depression operates and who is most at risk. As the researchers explain, "This study sheds light into the genetic architecture of depression and provides new insight into the interrelatedness of complex psychiatric traits."
INFORMATION:
The Million Veteran Program is VA's national research program aimed at learning how genes, lifestyle, and military exposures affect health and illness. As of May 2021, nearly 840,000 Veterans have volunteered for MVP.
Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.
The paper "Antidepressants produce persistent Gαs associated signaling changes in lipid rafts following drug withdrawal," published in the journal Molecular Pharmacology, addresses the molecular and cellular mechanisms that cause antidepressant withdrawal syndrome.
The study's authors, Mark Rasenick, distinguished professor of physiology and biophysics and psychiatry at UIC and research career scientist at the Jesse Brown VA Medical Center, and Nicholas ...
Higher percentage of patients treated with nivolumab and ipilimumab in clinical trial reach the six-and-a-half-year survival mark than those treated with either drug alone.
BOSTON - In the longest follow-up results from a clinical trial of combination immunotherapy for metastatic melanoma, investigators report that nearly half the patients who received the drugs nivolumab and ipilimumab were alive a median of six and a half years after treatment. The results, stemming from the CheckMate 067 clinical trial, represent a new landmark in survival rates for patients with melanoma treated with immune checkpoint inhibitor drugs.
F. ...
URBANA, Ill. - As the owner of a human body, you're carrying trillions of microbes with you everywhere you go. These microscopic organisms aren't just hitching a ride; many of them perform essential chemical reactions that regulate everything from our digestion to our immune system to our moods.
One important set of reactions relates to fat absorption via bile acids. Our livers make these acids to help digest fats and fat-soluble vitamins as they travel through the small intestine. Near the end of the small intestine, microbes convert the acids into new forms, which can either be beneficial or ...
Over the past 20 years, first-principles simulations have become powerful, widely used tools in many, diverse fields of science and engineering. From nanotechnology to planetary science, from metallurgy to quantum materials, they have accelerated the identification, characterization, and optimization of materials enormously. They have led to astonishing predictions--from ultrafast thermal transport to electron-phonon mediated superconductivity in hydrides to the emergence of flat bands in twisted-bilayer graphene-- that have gone on to inspire remarkable experiments.
The current push to complement ...
WASHINGTON -- Researchers have developed a new technique that allows microscopic fluorescence imaging at four times the depth limit imposed by light diffusion. Fluorescence microscopy is often used to image molecular and cellular details of the brain in animal models of various diseases but, until now, has been limited to small volumes and highly invasive procedures due to intense light scattering by the skin and skull.
"Visualization of biological dynamics in an unperturbed environment, deep in a living organism, is essential for understanding the complex biology of living organisms ...
Five years on from the first discovery of gravitational waves, an international team of scientists, including from the ARC Centre of Excellence for Gravitational Wave Discovery (OzGrav), are continuing the hunt for new discoveries and insights into the Universe. Using the super-sensitive, kilometre-sized LIGO detectors in the United States, and the Virgo detector in Europe, the team have witnessed the explosive collisions of black holes and neutron stars. Recent studies, however, have been looking for something quite different: the elusive signal from a solitary, rapidly-spinning neutron star.
Take a star similar in size to the Sun, squash it down to a ball about ...
The hunt for the never before heard "hum" of gravitational waves caused by mysterious neutron stars has just got a lot easier, thanks to an international team of researchers.
Gravitational waves have only been detected from black holes and neutron stars colliding, major cosmic events that cause huge bursts that ripple through space and time.
The research team, involving scientists from the LIGO Scientific Collaboration (LSC), Virgo Collaboration and the Centre for Gravitational Astrophysics (CGA) at The Australian National University (ANU), are now turning their eagle eye to spinning neutron stars to detect the waves.
Unlike the massive bursts caused by black holes or neutron stars colliding, the researchers ...
AMHERST, Mass. - New research by University of Massachusetts Amherst astronomer Daniel Wang reveals, with unprecedented clarity, details of violent phenomena in the center of our galaxy. The images, published recently in Monthly Notices of the Royal Astronomical Society, document an X-ray thread, G0.17-0.41, which hints at a previously unknown interstellar mechanism that may govern the energy flow and potentially the evolution of the Milky Way.
"The galaxy is like an ecosystem," says Wang, a professor in UMass Amherst's astronomy department, whose findings are a result of more than two decades of research. "We know the centers of galaxies are where the action is and play an enormous role in their evolution." And yet, whatever has ...
Individuals with genetic high cholesterol, heart disease or both, who were infected with COVID-19 had more heart attacks according to new research by the FH Foundation. While previous studies have speculated about poorer outcomes if a person with genetic high cholesterol - called familial hypercholesterolemia (FH) contracts COVID-19, this study from the FH Foundation's national healthcare database is the first to demonstrate higher heart attack rates in the real world. Published online in the American Journal of Preventive Cardiology, the study also importantly confirms that COVID-19 increases heart attack rates in individuals with established atherosclerotic cardiovascular disease (ASCVD).
The FH Foundation performed an analysis of 55,412,462 individuals, separating groups into six ...
Leesburg, VA, May 27, 2021--According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), accurate prenatal diagnosis of severe placental accreta spectrum (PAS) disorder by imaging could help guide maternal counseling and selection between hysterectomy and uterine-preserving surgery.
"The findings suggest strong performance of placental bulge in diagnosing severe PAS on both ultrasound and MRI, with potentially relatively stronger performance on MRI," wrote corresponding author Manjiri Dighe from the department of radiology at the University of Washington School of Medicine. "Nonetheless, interobserver agreement remains suboptimal on both modalities."
On ultrasound and MRI alike, the placental bulge sign represents ...
